Intermittent ESP Block via Subcutaneous Port for Lung Cancer Pain
Official title: Efficacy of Intermittent Erector Spinae Plane Block Via Subcutaneous Port for Cancer-Related Pain in Patients With Lung Cancer
Run by Hanoi Medical University · NCT07396558 · Data updated 2026-11-12
This study tests whether giving intermittent erector spinae plane (ESP) blocks through a subcutaneous port can better control chest wall–related cancer pain in adults with advanced lung cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Hanoi Medical University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Hanoi) |
| Status | Recruiting |
| Started | March 1, 2026 |
| Main results expected | September 1, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT07396558 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with advanced lung cancer and chronic localized chest pain who are already in palliative care and can have a subcutaneous port placed.
✕Probably not a fit
Patients without chest-wall or thoracic pain or those unlikely to benefit from regional analgesia may not experience improvement.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates the feasibility, safety, and effectiveness of delivering local anesthetic for cancer pain using an intermittent ESP block through a subcutaneous port. Eligible participants have advanced lung cancer with chronic thoracic pain and inadequate relief from standard analgesics. Pain intensity, analgesic needs, patient comfort, and adverse events are monitored over time to determine if this approach can improve multimodal pain management.
Why it matters
Potential benefit: If successful, patients may experience better pain relief and reduced reliance on systemic opioids.
How similar studies have gone: Regional anesthesia approaches for cancer pain have shown benefits in some settings, but the specific port-delivered intermittent ESP block for lung cancer pain is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Adult patients diagnosed with advanced-stage lung cancer who are currently receiving palliative care only. * Presence of chronic cancer-related chest pain lasting longer than 1 month, localized to the thoracic region due to chest wall invasion, pleural involvement, or bone metastases. * Performance status ≤ 3 according to the Eastern Cooperative Oncology Group (ECOG), allowing placement of a subcutaneous port and maintenance of local anesthetic administration. * Inadequate pain control with conventional analgesic therapies or clinical indication for the addition of regional analgesia. * Ability to understand the study procedures and provide written informed consent after receiving a full explanation of the intervention. Exclusion Criteria: * Chest pain with radiation to the upper extremities, neck, or shoulder, suggestive of non-localized thoracic pain. * Severe hepatic or renal dysfunction, or severe heart failure (New York Heart Association class III-IV). * Local infection at the injection or port placement site, or uncontrolled systemic infection. * Severe cachexia or insufficient subcutaneous tissue that does not allow safe coverage of the subcutaneous port. * Known allergy to amide-type local anesthetics or other contraindications to regional anesthesia. * Severe cognitive impairment, altered consciousness, or inability to cooperate with post-intervention monitoring. * Lack of adequate caregiver support for home-based follow-up after discharge or inability to coordinate follow-up with local healthcare facilities. * Severe coagulation disorders, defined as: * International normalized ratio (INR) \> 1.5 * Activated partial thromboplastin time (aPTT) \> 40 seconds * Fibrinogen \< 1.5 g/L * Platelet count \< 50 × 10⁹/L.
Where it's running
-
Hanoi Medical University
Hanoi, Vietnam Recruiting
Study contacts
- Study coordinator: Vu Hoang Phuong, MD, PhD
- Email: vuhoangphuong@hmu.edu.vn
- Phone: +84912300978
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)
This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.
-
Nerve block to treat severe belly pain in the emergency department
This study tests whether injecting anesthesia into the erector spinae plane can relieve non-surgical abdominal pain in the ED without relying on narcotics.
-
Cervical ESPB to help pain after proximal humerus repair
This study tests whether a cervical erector spinae plane block helps manage postoperative pain after surgery to fix a proximal humeral fracture in adults under general anesthesia.
-
Single-level vs two-level erector spinae plane block for breast surgery
This study tests whether a single-level ESPB provides similar pain relief to a two-level ESPB for adults undergoing breast surgery.
-
Midpoint transverse process to pleura block vs erector spinae plane block for thoracic herpes zoster pain
This study compares two ultrasound-guided nerve blocks to see which better eases pain from thoracic herpes zoster in adults 21–60.
-
Continuous ESP Block for Analgesia After CABG Surgery
This trial tests whether a continuous erector spinae plane (ESP) block with ropivacaine, delivered via catheter and patient-controlled analgesia, provides better postoperative pain relief than placebo in patients undergoing coronary artery bypass grafting.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.